Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis

The efficacy and safety of aliskiren combination therapy with angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in patients with hypertension and cardiovascular disease remains attractive attention. We searched the Cochrane Central Register, the Clinical Trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Shufang, Wen, Xin, Han, Fei, Long, Yin, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687695/
https://www.ncbi.nlm.nih.gov/pubmed/29179525
http://dx.doi.org/10.18632/oncotarget.19382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687695/
https://www.ncbi.nlm.nih.gov/pubmed/29179525
http://dx.doi.org/10.18632/oncotarget.19382

Ejemplares similares